DOCS vs VRSN: stock comparison and AI forecast
Doximity, Inc. (DOCS) and Verisign Inc/Ca (VRSN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DOCS Doximity, Inc.
- Market Cap
- $5.97B
- P/E Ratio
- 39.0x
- Size
- mid-cap
- AI Forecast
VRSN Verisign Inc/Ca
- Price
- $312.06 +12.1% · 6M
- Market Cap
- $27.99B
- P/E Ratio
- 33.6x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- VRSN is 4.7 times larger than DOCS by market capitalization ($27.99B against $5.97B).
- VRSN trades at 33.5 times trailing earnings, DOCS at 39.0 times.
- VRSN turns 49.1% of its revenue into net income, against 21.1% for DOCS.
- VRSN yields 1.04% in dividends; DOCS pays none.
- Both companies share the SEC industry classification Services-Computer Programming Services.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DOCS | VRSN |
|---|---|---|
| Market Cap | $5.97B | $27.99B |
| P/E Ratio | 39.04x | 33.55x |
| P/B Ratio | 6.43x | – |
| Dividend Yield | – | 1.04% |
| EPS | $0.85 | $9.30 |
| Book Value/Share | $5.16 | – |
| Revenue/Share | $3.68 | $19.31 |
| FCF/Share | – | $11.41 |
Profitability & Margins
| Metric | DOCS | VRSN |
|---|---|---|
| ROE | 15.1% | – |
| ROA | 12.8% | 66.4% |
| ROIC | 18.4% | – |
| Gross Margin | 86.8% | 88.6% |
| Operating Margin | 26.3% | 67.6% |
| Net Margin | 21.1% | 49.1% |
| EBT Margin | 30.8% | 64.2% |
| Tax Rate | 31.4% | 23.6% |
Financial Health
| Metric | DOCS | VRSN |
|---|---|---|
| Current Ratio | 6.37x | 0.42x |
| D/E Ratio | 0.18x | – |
| Financial Leverage | 1.18x | – |
| Interest Coverage | – | 14.0x |
| Working Capital | $777M | -$808M |
Cash Flow
| Metric | DOCS | VRSN |
|---|---|---|
| Operating Cash Flow | $306M | $1.06B |
| Free Cash Flow | – | $1.02B |
| Capital Spending | – | -$38M |
| OCF Growth YoY | -4.4% | 2.8% |
| FCF Growth YoY | – | 1.9% |
| FCF/Sales | – | 59.1% |
| CapEx/Sales | – | 2.2% |
Operational Efficiency
| Metric | DOCS | VRSN |
|---|---|---|
| Asset Turnover | 0.61x | 1.35x |
| Receivables Turnover | 4.0x | 180.4x |
| Fixed Assets Turnover | 33.4x | 7.8x |
| Days Sales Outstanding | 92 days | 2 days |
| Payables Period | 26 days | 529 days |
Income Statement
| Metric | DOCS | VRSN |
|---|---|---|
| Total Revenue | $662M | $1.73B |
| Operating Income | $174M | $1.17B |
| Net Income | $140M | $850M |
| R&D Expense | $154M | $108M |
| SG&A Expense | $649M | $255M |
| Cost of Goods Sold | $87M | $198M |
Dividend & Shareholder Information
| Metric | DOCS | VRSN |
|---|---|---|
| Dividends Per Share | – | $3.25 |
| Payout Ratio | – | 35.0% |
| Shares Outstanding | 180M | 90M |
| Net Income Growth | -44.8% | 4.8% |
| EPS Growth | -29.2% | 8.4% |
DOCS vs VRSN: stock comparison and AI forecast
Which is bigger, DOCS or VRSN?
VRSN is 4.7 times larger than DOCS by market capitalization ($27.99B against $5.97B).
Which is cheaper on earnings, DOCS or VRSN?
VRSN trades at 33.5 times trailing earnings, DOCS at 39.0 times.
Which one does Intratio's AI model rank higher, DOCS or VRSN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.